TradingView
RocketTickers
26 de Sep. de 2018 16:28
Aldeyra Therapeutics Announces Positive Results from Phase 2b
Largo
NASDAQ:ALDX
1D
Aldeyra Therapeutics, Inc.
NASDAQ
Descripción
⋅
26 de Sep. de 2018 16:28
ALDX : Aldeyra Therapeutics, Inc.
2018-09-26 07:00:00
Aldeyra Therapeutics Announces Positive Results from Phase 2b Dry Eye Disease Clinical Trial
Beyond Technical Analysis
Más